Details for New Drug Application (NDA): 061734
✉ Email this page to a colleague
NDA 061734 describes ROBITET, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the ROBITET profile page.
The generic ingredient in ROBITET is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
The generic ingredient in ROBITET is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
Summary for 061734
| Tradename: | ROBITET |
| Applicant: | Wyeth Ayerst |
| Ingredient: | tetracycline hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
